These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28396438)

  • 21. Regulatory Harmonization and Streamlining of Clinical Trial Applications globally should lead to faster clinical development and earlier access to life-saving vaccines.
    Scheppler L; De Clercq N; McGoldrick M; Dias J
    Vaccine; 2021 Jan; 39(5):790-796. PubMed ID: 33422378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory Antibodies Targeting Emerging Viruses: Advancements and Mechanisms.
    Jin J; Simmons G
    Clin Vaccine Immunol; 2016 Jul; 23(7):535-9. PubMed ID: 27226280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Climate change, its impact on emerging infectious diseases and new technologies to combat the challenge.
    Liao H; Lyon CJ; Ying B; Hu T
    Emerg Microbes Infect; 2024 Dec; 13(1):2356143. PubMed ID: 38767202
    [No Abstract]   [Full Text] [Related]  

  • 24. Development of a One Health National Capacity in Africa : the Southern African Centre for Infectious Disease Surveillance (SACIDS) One Health Virtual Centre Model.
    Rweyemamu M; Kambarage D; Karimuribo E; Wambura P; Matee M; Kayembe JM; Mweene A; Neves L; Masumu J; Kasanga C; Hang'ombe B; Kayunze K; Misinzo G; Simuunza M; Paweska JT
    Curr Top Microbiol Immunol; 2013; 366():73-91. PubMed ID: 22820706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.
    Leblanc P; Moise L; Luza C; Chantaralawan K; Lezeau L; Yuan J; Field M; Richer D; Boyle C; Martin WD; Fishman JB; Berg EA; Baker D; Zeigler B; Mais DE; Taylor W; Coleman R; Warren HS; Gelfand JA; De Groot AS; Brauns T; Poznansky MC
    Hum Vaccin Immunother; 2014; 10(10):3022-38. PubMed ID: 25483693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine innovations for emerging infectious diseases-a symposium report.
    Cable J; Srikantiah P; Crowe JE; Pulendran B; Hill A; Ginsberg A; Koff W; Mathew A; Ng T; Jansen K; Glenn G; Permar S; Wilson I; Weiner DB; Weissman D; Rappuoli R
    Ann N Y Acad Sci; 2020 Feb; 1462(1):14-26. PubMed ID: 31659752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A strategic vaccine facility for the UK.
    Duggan JM; Brooks TJ
    Vaccine; 2005 Mar; 23(17-18):2090-4. PubMed ID: 15755577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global convergence of emerging infectious diseases: Only a plane ride away.
    Chapman C; Delahanty K
    Nursing; 2018 Feb; 48(2):14-16. PubMed ID: 29369273
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of systems biology approaches in determining molecular signatures for the development of more effective vaccines.
    Pezeshki A; Ovsyannikova IG; McKinney BA; Poland GA; Kennedy RB
    Expert Rev Vaccines; 2019 Mar; 18(3):253-267. PubMed ID: 30700167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using cross-species vaccination approaches to counter emerging infectious diseases.
    Warimwe GM; Francis MJ; Bowden TA; Thumbi SM; Charleston B
    Nat Rev Immunol; 2021 Dec; 21(12):815-822. PubMed ID: 34140665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The new International Health Regulations: considerations for global public health surveillance.
    Sturtevant JL; Anema A; Brownstein JS
    Disaster Med Public Health Prep; 2007 Nov; 1(2):117-21. PubMed ID: 18388639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Another emerging arbovirus, another emerging vaccine: Targeting Zika virus.
    Palacios R; Poland GA; Kalil J
    Vaccine; 2016 Apr; 34(20):2291-3. PubMed ID: 27015734
    [No Abstract]   [Full Text] [Related]  

  • 33. Emerging infectious diseases with cutaneous manifestations: Viral and bacterial infections.
    Nawas ZY; Tong Y; Kollipara R; Peranteau AJ; Woc-Colburn L; Yan AC; Lupi O; Tyring SK
    J Am Acad Dermatol; 2016 Jul; 75(1):1-16. PubMed ID: 27317512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens.
    Fan Y; Moon JJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jan; 9(1):. PubMed ID: 27038091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Environmental and social influences on emerging infectious diseases: past, present and future.
    McMichael AJ
    Philos Trans R Soc Lond B Biol Sci; 2004 Jul; 359(1447):1049-58. PubMed ID: 15306389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rethinking the Response to Emerging Microbes: Vaccines and Therapeutics in the Ebola Era--a Conference at Harvard Medical School.
    Knipe DM; Whelan SP
    J Virol; 2015 Aug; 89(15):7446-8. PubMed ID: 25995250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nervous System Infections and the Global Traveler.
    Reid S; Thompson H; Thakur KT
    Semin Neurol; 2018 Apr; 38(2):247-262. PubMed ID: 29791951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Emergent pathogens, international surveillance and international health regulations (2005)].
    Formenty P; Roth C; Gonzalez-Martin F; Grein T; Ryan M; Drury P; Kindhauser MK; Rodier G
    Med Mal Infect; 2006 Jan; 36(1):9-15. PubMed ID: 16309873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role.
    Bozzo J; Jorquera JI
    Expert Rev Anti Infect Ther; 2017 Jun; 15(6):585-604. PubMed ID: 28480779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging diseases and implications for Millennium Development Goals in Africa by 2015 - an overview.
    Aluwong T; Bello M
    Vet Ital; 2010; 46(2):137-45. PubMed ID: 20560123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.